BRIEF-Sino Biopharmaceutical Says Dabigatran Etexilate Capsules Developed By Unit Gets Approval For Drug Registration Granted By NMPA

March 20 (Reuters) - Sino Biopharmaceutical Ltd:

* SINO BIOPHARMACEUTICAL LTD- DABIGATRAN ETEXILATE CAPSULES DEVELOPED BY UNIT OBTAINED APPROVAL FOR DRUG REGISTRATION GRANTED BY NMPA OF PRC Source text for Eikon: Further company coverage: